Biomedical subjects

M Liscovitch

Publications and source records attributed to M Liscovitch.

60 records · Page 4Linked to original sources

PubMed1985

Intracellular pathways of receptor-bound GnRH agonist in pituitary gonadotropes.

Localization of GnRH receptors in rat pituitary gonadotropes was studied by use of 125I-[azidobenzoyl-D-Lys6]GnRH which, upon photolysis, is covalently bound to the receptor molecule. Using high resolution autoradiography, it was found that, after a 90-min incubation of the analog with pituitary cells at 4 degrees C, 93% of the silver grains were associated with the plasma membrane of the gonadotropes. After 45-min incubation of the cells at 37 degrees C, clustering and internalization of the receptor-bound GnRH analog were evident. Silver grains were associated with coated pits, intracellular vesicles, Golgi complexes, lysosome-like structures and secretory granules. The data indicate that receptor-bound GnRH agonist is internalized, at least in part, via coated pits and is subsequently routed to lysosomes where degradation of the hormone-receptor complex may occur. The presence of a considerable amount of silver grains associated with secretory granules may suggest that some of the internalized receptor molecules can escape degradation and be recycled to the cell membrane.

Animals↗

PubMed1984

A differential effect of trypsin on pituitary gonadotropin-releasing hormone receptors from intact and ovariectomized rats. Evidence for the existence of two distinct receptor populations.

The present report demonstrates that pituitary receptors for gonadotropin-releasing hormone generated following ovariectomy are susceptible to the action of trypsin while those present in intact metestrous females are not. The action of trypsin of gonadotropin-releasing hormone receptors in pituitary cells derived from ovariectomized rats was dependent on time and dose. Trypsin exerted a maximal effect of 40-50% reduction without causing full abolition of the binding activity, indicating that two populations of gonadotropin-releasing hormone receptors can be differentiated in pituitaries derived from ovariectomized rats: one which is sensitive to limited proteolysis by trypsin and another which is resistant to it. Scatchard analysis of gonadotropin-releasing hormone antagonist binding to homogenate of trypsin-treated hemipituitaries derived from ovariectomized rats, revealed that trypsin reduced receptor density while slightly increasing binding affinity. The in vitro responsiveness of hemipituitaries from ovariectomized rats to gonadotropin-releasing hormone and to K+-induced depolarization was reduced following trypsin treatment, while that of hemipituitaries derived from metestrous females was not affected or increased. Trypsin reduced the maximal response level by 30-50% but did not modify the median effective dose of gonadotropin-releasing hormone (1 nM). The reduced gonadotropin-releasing hormone receptor density and the lower responsiveness caused by trypsin in pituitary tissue from ovariectomized rats are not due to a selective loss of gonadotrophs, as trypsin treatment did not affect the lutropin content of the glands. These findings indicate that two populations of gonadotropin-releasing hormone receptors can be distinguished on the basis of their susceptibility or resistance to limited proteolysis by trypsin and suggest that these two gonadotropin-releasing hormone receptor populations are reciprocally affected by ovariectomy.

Animals↗

PubMed1983

Receptor-mediated internalization of LHRH antagonists by pituitary cells.

A fluorescently labeled antagonist of luteinizing hormone releasing hormone (LHRH), D-pGlu-D-Phe-D-Trp-Ser-Tyr-D-Lys6-(tetramethylrhodamine)-Leu-Arg-Pro-Gly-NH2, was prepared. This peptide retained high-affinity binding to the LHRH receptor of pituitary plasma membrane preparations. The analog was able to block LHRH-stimulated LH release from pituitaries incubated in vitro, and exhibited minor agonistic activity. This rhodamine-labeled antagonist was utilized for the microscopic visualization and localization of LHRH receptors in dispersed rat pituitary cells. The fluorescently labeled receptors were initially distributed uniformly on the cell surface. The hormone-receptor complexes were redistributed after incubation at 23 degrees C and formed clusters which subsequently became internalized (at 37 degrees C) into endocytic vesicles. Addition of LHRH (10(-6) M) abolished these processes, indicating specific binding sites for the rhodamine-labeled peptide to the gonadotrope cells. A quantitative comparison of temperature-dependent internalization by iodinated LHRH agonist and antagonist revealed that both analogs were internalized to a similar extent. These findings suggest that LHRH-receptor complex internalization is related to LHRH receptor regulation.

Animals↗

PubMedDate not supplied

Characterization and subcellular localization of GnRH analog binding in rat brain.

The binding of a degradation-resistant analog of gonadotropin-releasing hormone, [D-Phe6]GnRH, to rat brain crude particulate preparation was studied. The binding of this analog at 0 degrees C was saturable and Scatchard analysis revealed the presence of 2 binding sites: one with KD = 1.39 x 10(-7) M and Bmax = 265 pmole/mg protein, and another of lower affinity but higher capacity with KD = 5.58 X 10(-6) M and Bmax = 1734 pmoles/mg protein. The binding at 0 degrees C was substantially higher than that obtained at 37 degrees C, due to binding site-inactivation processes occurring at 37 degrees C. The binding sites exhibited a considerable degree of specificity for GnRH as unrelated peptides (with the exception of ACTH) display a much weaker affinity than GnRH and GnRH analogs. Subcellular fractionation demonstrated that most of the binding was associated with the mitochondrial fraction.

Adrenocorticotropic Hormone↗

PubMedDate not supplied

Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences.

The carcinogenic process involves a complex series of genetic and biochemical changes that enables transformed cells to proliferate, migrate to secondary sites and, in some cases, acquire mechanisms that make cancer cells resistant to chemotherapy. This phenomenon in its most common form is known as multidrug resistance (MDR). It is usually mediated by overexpression of P-glycoprotein (P-gp) or other plasma membrane ATPases that export cytotoxic drugs used in chemotherapy, thereby reducing their efficacy. However, additional adaptive changes are likely to be required in order to confer a full MDR phenotype. Recent studies have shown that acquisition of MDR is accompanied by upregulation of lipids and proteins that constitute lipid rafts and caveolar membranes, notably glucosylceramide and caveolin. These changes may be related to the fact that in MDR cells a significant fraction of cellular P-gp is associated with caveolin-rich membrane domains, they may be involved in drug transport and they could have an impact on drug-induced apoptosis and on the phenotypic transformation of MDR cancer cells.

Animals↗

PubMedDate not supplied

Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.

Intrinsic or acquired resistance of tumor cells to multiple cytotoxic drugs (multidrug resistance MDR) is a major cause of failure of cancer chemotherapy. MDR is often caused by elevated expression of drug transporters such as P-glycoprotein (P-gp) or multidrug resistance protein (MRP). A number of compounds, termed chemosensitizers, have little or no cytotoxic action of their own, but inhibit (P-gp) or MRP-mediated drug export and are capable of sensitizing MDR cells to the cytotoxic effects of chemotherapeutic drugs. Here we examined the ability of steroidal alkaloids of plant origin, namely the Veratrum sp. alkaloid cyclopamine and the Lycopersicon sp. alkaloid tomatidine, to act as potent and effective chemosensitizers in multidrug resistant tumor cells. Drug uptake was determined by measuring accumulation of tetramethylrosamine in multidrug resistant NCI AdrR human adenocarcinoma cells. Resistance to adriamycin and vinblastine was determined by utilizing the MTT cell survival assay. Cyclopamine and tomatidine elevate tetramethylrosamine uptake by NCI AdrR cells and sensitize the cells to the cytotoxic action of adriamycin and vinblastine. In both cases these agents are comparable in patency and efficacy to verapamil, a reversal agent commonly used in MDR research. It is concluded that steroidal alkaloids of plant origin act as inhibitors of P-gp-mediated drug transport and multidrug resistance and therefore may serve as chemosensitizers in combination chemotherapy with conventional cytotoxic drugs for treating multidrug resistant cancer.

ATP Binding Cassette Transporter, Subfamily B, Mem↗